SLU-PP-332 and Exercise Mimetics: The ERR Pathway in Research
Can a molecule reproduce the cellular program of endurance training? SLU-PP-332 targets the estrogen-related receptors to ask exactly that question in preclinical models.
Can a molecule reproduce the cellular program of endurance training? SLU-PP-332 targets the estrogen-related receptors to ask exactly that question in preclinical models.
A small molecule that blocks a single enzyme — NNMT — and in doing so preserves the cellular currency of NAD+ metabolism. Why laboratories are paying attention.
From thymic extract to one of the most studied immune research peptides — how Thymosin Alpha-1 is used in T-cell, TLR, and immunomodulation research.
Five receptors, one hormone family, wildly different biology — from pigmentation to appetite to inflammation. How MT-1, MT-2, PT-141, and KPV map onto the melanocortin system.
Discovered through a tumor suppressor gene, kisspeptin turned out to be the master switch of the reproductive hormone axis. How laboratories use it to probe GnRH signaling.
A four amino acid peptide from Russian gerontology programs became one of the most discussed compounds in aging research. A sober look at the Epitalon literature.
GHK-Cu is one of the most published compounds in skin biology — a naturally occurring copper complex whose plasma levels decline with age. What the research record actually shows.
KLOW and GLOW share three components but differ by one peptide — and that difference defines their research profiles. A breakdown of both blends and when each fits a study design.
Before dual and triple agonists, semaglutide defined incretin research. Its mechanism, its role as the reference compound, and how laboratories use the GLP-1 class today.
Tirzepatide proved that two incretin receptors beat one — reshaping metabolic research. The mechanism, the evidence, and how laboratories study the dual agonist class.